Medicxi Closes €500m Fund V for Index Spinout
ByAinvest
Friday, Nov 14, 2025 4:14 pm ET1min read
GH--
MRNA--
Medicxi, a healthcare-focused venture capital firm spun out of Index Ventures, has closed its fifth fund with €500m in commitments. The fund will focus on early-stage investments in biotech, medtech, and healthcare services companies in Europe and the US. Medicxi has a track record of successful exits and has invested in companies such as Moderna and Guardant Health. The firm's new fund will allow it to continue supporting innovative healthcare startups and scale its portfolio companies.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet